Colgate-Palmolive (NYSE:CL) is a leading global company in the consumer products sector. It specializes in household and personal care items, including oral care products. The company also owns Hill's, a specialty pet food maker, which contributes nearly a quarter of its total sales. This diverse product portfolio helps it maintain a strong market presence and competitive advantage.
On May 1, 2026, investment firm Goldman Sachs reaffirmed its "Buy" rating for Colgate-Palmolive. The firm also increased its price target for the stock to $100.00, up from the previous target of $98.00. At the time of this announcement, the stock was trading at $87.26, suggesting potential for future stock growth and positive investment analysis.
This positive outlook is supported by the company's recent financial results. For the first quarter of 2026, Colgate-Palmolive reported that its net sales grew by 8.4% to $5.32 billion, slightly beating revenue estimates. As highlighted by Reuters, this strong performance was driven by robust international demand for its household and personal care products.
The company's profitability also shows strength. Its Base Business earnings per share (EPS), a key measure of profit per share from core operations, increased by 7% to $0.97. This figure beat analyst estimates. As highlighted by Zacks, Colgate-Palmolive has now surpassed consensus EPS estimates for four consecutive quarters, demonstrating a consistent trend of strong financial performance.
However, the company's GAAP diluted EPS, which follows standard accounting rules, fell by 6% to $0.80. This missed the projected $0.96. Following the news, shares of Colgate-Palmolive rose by 2.23%, with a trading volume of about 8.93 million shares and a market capitalization of approximately $70.01 billion, reflecting mixed investor sentiment.
